HLA-DRw4 in Felty's syndrome. 1980

H J Dinant, and W Hissink Muller, and E M van den Berg-Loonen, and L E Nijenhuis, and C P Engelfriet

UI MeSH Term Description Entries
D005258 Felty Syndrome A rare complication of rheumatoid arthritis with autoimmune NEUTROPENIA; and SPLENOMEGALY. Felty's Syndrome,Familial Felty Syndrome,Familial Felty's Syndrome,Rheumatoid Arthritis, Splenomegaly and Neutropenia,Familial Feltys Syndrome,Felty Syndrome, Familial,Felty's Syndrome, Familial,Feltys Syndrome,Syndrome, Familial Felty,Syndrome, Familial Felty's,Syndrome, Felty,Syndrome, Felty's
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000949 Histocompatibility Antigens Class II Large, transmembrane, non-covalently linked glycoproteins (alpha and beta). Both chains can be polymorphic although there is more structural variation in the beta chains. The class II antigens in humans are called HLA-D ANTIGENS and are coded by a gene on chromosome 6. In mice, two genes named IA and IE on chromosome 17 code for the H-2 antigens. The antigens are found on B-lymphocytes, macrophages, epidermal cells, and sperm and are thought to mediate the competence of and cellular cooperation in the immune response. The term IA antigens used to refer only to the proteins encoded by the IA genes in the mouse, but is now used as a generic term for any class II histocompatibility antigen. Antigens, Immune Response,Class II Antigens,Class II Histocompatibility Antigen,Class II Major Histocompatibility Antigen,Ia Antigens,Ia-Like Antigen,Ia-Like Antigens,Immune Response Antigens,Immune-Associated Antigens,Immune-Response-Associated Antigens,MHC Class II Molecule,MHC II Peptide,Class II Antigen,Class II Histocompatibility Antigens,Class II MHC Proteins,Class II Major Histocompatibility Antigens,Class II Major Histocompatibility Molecules,I-A Antigen,I-A-Antigen,IA Antigen,MHC Class II Molecules,MHC II Peptides,MHC-II Molecules,Antigen, Class II,Antigen, I-A,Antigen, IA,Antigen, Ia-Like,Antigens, Class II,Antigens, Ia,Antigens, Ia-Like,Antigens, Immune-Associated,Antigens, Immune-Response-Associated,I A Antigen,II Peptide, MHC,Ia Like Antigen,Ia Like Antigens,Immune Associated Antigens,Immune Response Associated Antigens,MHC II Molecules,Molecules, MHC-II,Peptide, MHC II,Peptides, MHC II
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis
D044383 Black People Persons having origins in any of the black racial groups of AFRICA. Note that OMB category BLACK OR AFRICAN AMERICAN is available for the United States population groups. Race and ethnicity terms, as used in the federal government, are self-identified social construct and may include terms outdated and offensive in MeSH to assist users who are interested in retrieving comprehensive search results for studies such as in longitudinal studies. African Continental Ancestry Group,Black Person,Negroid Race,Black Peoples,Black Persons,Negroid Races,People, Black,Person, Black,Persons, Black,Race, Negroid

Related Publications

H J Dinant, and W Hissink Muller, and E M van den Berg-Loonen, and L E Nijenhuis, and C P Engelfriet
June 1985, The Journal of rheumatology,
H J Dinant, and W Hissink Muller, and E M van den Berg-Loonen, and L E Nijenhuis, and C P Engelfriet
March 1979, Lancet (London, England),
H J Dinant, and W Hissink Muller, and E M van den Berg-Loonen, and L E Nijenhuis, and C P Engelfriet
March 1979, Lancet (London, England),
H J Dinant, and W Hissink Muller, and E M van den Berg-Loonen, and L E Nijenhuis, and C P Engelfriet
March 1979, Lancet (London, England),
H J Dinant, and W Hissink Muller, and E M van den Berg-Loonen, and L E Nijenhuis, and C P Engelfriet
February 1986, Tissue antigens,
H J Dinant, and W Hissink Muller, and E M van den Berg-Loonen, and L E Nijenhuis, and C P Engelfriet
November 1980, Clinical immunology and immunopathology,
H J Dinant, and W Hissink Muller, and E M van den Berg-Loonen, and L E Nijenhuis, and C P Engelfriet
April 1979, Lancet (London, England),
H J Dinant, and W Hissink Muller, and E M van den Berg-Loonen, and L E Nijenhuis, and C P Engelfriet
May 1978, Lancet (London, England),
H J Dinant, and W Hissink Muller, and E M van den Berg-Loonen, and L E Nijenhuis, and C P Engelfriet
September 1980, Tissue antigens,
H J Dinant, and W Hissink Muller, and E M van den Berg-Loonen, and L E Nijenhuis, and C P Engelfriet
April 1979, Lancet (London, England),
Copied contents to your clipboard!